248 related articles for article (PubMed ID: 21501281)
1. Contraceptive vaccines for the humane control of community cat populations.
Levy JK
Am J Reprod Immunol; 2011 Jul; 66(1):63-70. PubMed ID: 21501281
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive vaccines: success, status, and future perspective.
Naz RK
Am J Reprod Immunol; 2011 Jul; 66(1):2-4. PubMed ID: 21645164
[No Abstract] [Full Text] [Related]
3. Contraceptive vaccines for wildlife: a review.
Kirkpatrick JF; Lyda RO; Frank KM
Am J Reprod Immunol; 2011 Jul; 66(1):40-50. PubMed ID: 21501279
[TBL] [Abstract][Full Text] [Related]
4. Contraceptive vaccines based on the zona pellucida glycoproteins for dogs and other wildlife population management.
Gupta SK; Srinivasan VA; Suman P; Rajan S; Nagendrakumar SB; Gupta N; Shrestha A; Joshi P; Panda AK
Am J Reprod Immunol; 2011 Jul; 66(1):51-62. PubMed ID: 21501280
[TBL] [Abstract][Full Text] [Related]
5. Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats.
Eade JA; Roberston ID; James CM
Reproduction; 2009 Jun; 137(6):913-22. PubMed ID: 19279201
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of GnRH and porcine zona pellucida (PZP) immunocontraceptive vaccines for controlling reproduction in white-tailed deer (Odocoileus virginianus).
Curtis PD; Pooler RL; Richmond ME; Miller LA; Mattfeld GF; Quimby FW
Reprod Suppl; 2002; 60():131-41. PubMed ID: 12220153
[TBL] [Abstract][Full Text] [Related]
7. Long-term fertility control in female cats with GonaCon™, a GnRH immunocontraceptive.
Levy JK; Friary JA; Miller LA; Tucker SJ; Fagerstone KA
Theriogenology; 2011 Nov; 76(8):1517-25. PubMed ID: 21835455
[TBL] [Abstract][Full Text] [Related]
8. Possible mechanisms of mammalian immunocontraception.
Barber MR; Fayrer-Hosken RA
J Reprod Immunol; 2000 Mar; 46(2):103-24. PubMed ID: 10706942
[TBL] [Abstract][Full Text] [Related]
9. Controlling animal populations using anti-fertility vaccines.
Fayrer-Hosken R
Reprod Domest Anim; 2008 Jul; 43 Suppl 2():179-85. PubMed ID: 18638121
[TBL] [Abstract][Full Text] [Related]
10. Serum antibody immunoreactivity to equine zona protein after SpayVac vaccination.
Mask TA; Schoenecker KA; Kane AJ; Ransom JI; Bruemmer JE
Theriogenology; 2015 Jul; 84(2):261-7. PubMed ID: 25922172
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and contraceptive efficacy of Escherichia coli-expressed recombinant porcine zona pellucida proteins.
Gupta N; Chakrabarti K; Prakash K; Wadhwa N; Gupta T; Gupta SK
Am J Reprod Immunol; 2013 Aug; 70(2):139-52. PubMed ID: 23444974
[TBL] [Abstract][Full Text] [Related]
12. Zona pellucida antigens: targets for contraceptive vaccines.
Skinner SM; Prasad SV; Ndolo TM; Dunbar BS
Am J Reprod Immunol; 1996 Mar; 35(3):163-74. PubMed ID: 8962642
[No Abstract] [Full Text] [Related]
13. Contraceptive potential of the porcine zona pellucida vaccine in the African elephant (Loxodonta africana).
Fayrer-Hosken RA; Bertschinger HJ; Kirkpatrick JF; Grobler D; Lamberski N; Honneyman G; Ulrich T
Theriogenology; 1999 Oct; 52(5):835-46. PubMed ID: 10735124
[TBL] [Abstract][Full Text] [Related]
14. An overview of the symposium: where have we been and where are we going?
Kirkpatrick JF
Reprod Suppl; 2002; 60():203-9. PubMed ID: 12220161
[No Abstract] [Full Text] [Related]
15. Zona pellucida glycoproteins based immunocontraceptive vaccines: strategies for development and their applications.
Gupta SK; Choudhury S; Srivastava N; Ravi C
Indian J Exp Biol; 2003 Jul; 41(7):682-93. PubMed ID: 15255371
[TBL] [Abstract][Full Text] [Related]
16. Canine zona pellucida glycoprotein-3: up-scaled production, immunization strategy and its outcome on fertility.
Shrestha A; Srichandan S; Minhas V; Panda AK; Gupta SK
Vaccine; 2015 Jan; 33(1):133-40. PubMed ID: 25448113
[TBL] [Abstract][Full Text] [Related]
17. Development of contraceptive vaccines for humans using antigens derived from gametes (spermatozoa and zona pellucida) and hormones (human chorionic gonadotrophin): current status.
Naz RK; Sacco A; Singh O; Pal R; Talwar GP
Hum Reprod Update; 1995 Jan; 1(1):1-18. PubMed ID: 9080203
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone dynamics in mares following immunocontraception with anti-zona pellucida or -GnRH vaccines.
Joonè CJ; Schulman ML; Fosgate GT; Claes ANJ; Gupta SK; Botha AE; Human A; Bertschinger HJ
Theriogenology; 2018 Jan; 106():214-220. PubMed ID: 29096268
[TBL] [Abstract][Full Text] [Related]
19. Anti-sperm and anti-ovum vaccines: the selection of candidate antigens and the outcome of preclinical studies.
Isahakia MA; Bambra CS
Scand J Immunol Suppl; 1992; 11():118-22. PubMed ID: 1514025
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of zona pellucida antigens as potential candidates for immunocontraception.
Paterson M; Wilson MR; van Duin M; Aitken RJ
J Reprod Fertil Suppl; 1996; 50():175-82. PubMed ID: 8984181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
